Abeona therapeutics® announces appointment of bernhardt zeiher, md, fccp, facp, and eric crombez, md to its board of directors

Cleveland, aug. 14, 2024 (globe newswire) -- abeona therapeutics inc. (nasdaq: abeo) today announced the appointment of bernhardt g. zeiher, md, fccp, facp, and eric crombez, md as new independent members to its board of directors. dr. zeiher brings more than 20 years of drug development experience where, in various roles, he oversaw the approval of 15 new treatments that addressed unmet needs in serious diseases with few to no treatment options. dr. crombez currently serves as chief medical officer of ultragenyx pharmaceutical inc. and brings extensive expertise in the development and execution of clinical development programs for rare genetic disorders.
ABEO Ratings Summary
ABEO Quant Ranking